Prognostic Value of a Serum Panel of Inflammatory Factors in Non-Metastatic Nasopharyngeal Carcinoma Patients Undergoing Radical Radiotherapy with Adjuvant Chemotherapy
Ting Liang,1– 6 Ding Xiao,2,3,7 Shanshan Lu,2,3 Xu Ye,8 Zhiqiang Xiao1– 3 1National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, People’s Republic of China; 2Research Center of Carcinogenesis and Targeted Therapy, Xiangya Hospital, Ce...
Main Authors: | Liang T, Xiao D, Lu S, Ye X, Xiao Z |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-09-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/prognostic-value-of-a-serum-panel-of-inflammatory-factors-in-non-metas-peer-reviewed-fulltext-article-CMAR |
Similar Items
-
The prognostic value of weight loss during radiotherapy among patients with nasopharyngeal carcinoma: a large-scale cohort study
by: Ya-Nan Jin, et al.
Published: (2022-05-01) -
The role of chemotherapy in the treatment of stage II nasopharyngeal carcinoma: Retrospective analysis of the national cancer database
by: Zaheer Ahmed, et al.
Published: (2019-04-01) -
The Current Role of Adjuvant Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma
by: Lin Su, et al.
Published: (2021-02-01) -
Proposed prognostic subgroups and facilitated clinical decision-making for additional locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: a retrospective study based on recursive partitioning analysis
by: Yuyi Yao, et al.
Published: (2023-01-01) -
A Commentary on: Long-term outcomes of induction chemotherapy followed by intensity modulated radiotherapy and adjuvant chemotherapy in nasopharyngeal carcinoma patients with N3 disease
by: Firas Baidoun, et al.
Published: (2022-01-01)